SCHEMBL7877869

SCHEMBL7877869

CNC(N)=NC(=O)c1cc2cc(OC)ccc2[nH]1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 2/20 0.60
PDGFRA P16234 2/20 0.60
FLT3 P36888 7/20 0.54
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
MEN1 O00255 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
TSHR P16473 1/20 0.53
KMT2A Q03164 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
NPC1 O15118 1/20 0.53
LMNA P02545 1/20 0.53
HPGD P15428 1/20 0.53
HTT P42858 1/20 0.53
RAB9A P51151 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7880953 0.99 PDGFRB (0.59) PDGFRBPDGFRAFLT3KDM4EALDH1A1
SCHEMBL7877900 0.90 FLT3 (0.54) PDGFRBPDGFRAFLT3MEN1KMT2A
Hydrochloric Acid SCHEMBL7882033 0.89 FLT3 (0.53) PDGFRBPDGFRAFLT3MEN1KMT2A
SCHEMBL8176165 0.87 PDGFRB (0.56) PDGFRBPDGFRAFLT3KDM4EALDH1A1
Hydrochloric Acid SCHEMBL7884873 0.86 PDGFRB (0.56) PDGFRBPDGFRAKDM4EALDH1A1MEN1
Hydrochloric Acid SCHEMBL8688593 0.86 PDGFRB (0.65) PDGFRBPDGFRAFLT3KDM4EALDH1A1
SCHEMBL7879962 0.83 PIN1 (0.56) PDGFRBPDGFRAFLT3KDM4EALDH1A1
SCHEMBL7873277 0.83 FLT3 (0.55) PDGFRBPDGFRAFLT3
SCHEMBL7878275 0.83 HRH4 (0.48) PDGFRBPDGFRAFLT3KDM4EALDH1A1
SCHEMBL7877462 0.82 KDM4E (0.65) PDGFRBPDGFRAFLT3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed